We recently published a list of LOOK: These 10 Stocks Just Stole The Show. In this article, we are going to take a look at where Bausch Health Companies Inc. (NYSE:BHC) stands against other best-performing stocks of Friday.

Bausch Health extended its winning streak to a sixth consecutive day on Friday, ending 8.53 percent higher at $5.98 apiece after one of its directors acquired $15 million worth of shares in the company.

In a regulatory filing on Thursday, Bausch Health Companies Inc. (NYSE:BHC) said that its director, John Paulson, acquired nearly 2.79 million new shares through his company, Paulson Capital Inc., at a price of $5.05 to $5.47 apiece.

A series of pharmaceutical and medical products in a warehouse, displaying the range of products available.

No reason was divulged regarding the transaction, but investors may have taken the acquisition as a cue to bargain-hunt on its shares.

Paulson’s acquisition followed the listed firm’s regulatory filing earlier this week that one of its direct subsidiaries and two indirect subsidiaries are planning to raise more than $3 billion in fresh funds through the issuance of a loan facility and revolving credit facility.

On Tuesday, the listed firm’s direct arm, Bausch + Lomb Corporation, launched a 600-million euro ($693 million) senior notes offering on Tuesday.

This was on top of another $3 billion being raised by two indirect subsidiaries through a term B loan facility amounting to $2.2 billion and a revolving credit facility worth $800 million.

Bausch Health Companies Inc. (NYSE:BHC) said funds from the fundraising program will be used for the repayment of its direct subsidiary’s existing revolving credit facility, refinancing of term loans due 2027, and paying other fees and expenses, as well as general corporate purposes.

While we acknowledge the potential of BHC as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.

Disclosure: None. This article is originally published at Insider Monkey.